insulin glargine (Q21545): Difference between revisions
Jump to navigation
Jump to search
Created claim: chemical formula (P218): C₂₆₇H₄₀₄N₇₂O₇₈S₆ |
Added link to [en]: Insulin glargine |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / medical condition treated | |||||||||||||||
| Property / medical condition treated: maturity-onset diabetes of the young type 2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / medical condition treated | |||||||||||||||
| Property / medical condition treated: type-1 diabetes / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / medical condition treated | |||||||||||||||
| Property / medical condition treated: hyperglycemia / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / medical condition treated | |||||||||||||||
| Property / medical condition treated: type-1 diabetes / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / medical condition treated: type-1 diabetes / qualifier | |||||||||||||||
start time: 19 April 2000
| |||||||||||||||
| Property / medical condition treated: type-1 diabetes / qualifier | |||||||||||||||
| Property / subject has role | |||||||||||||||
| Property / subject has role: anti-diabetic medication / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / related image | |||||||||||||||
| Property / related image: Toujeo 300 IU-ml inj.jpg / rank | |||||||||||||||
Normal rank | |||||||||||||||
| links / en / name | links / en / name | ||||||||||||||
Latest revision as of 09:33, 20 March 2024
pharmaceutical drug
- HOE-901
- HOE-71GT
- Insulin Glargine (rDNA origin)
- Abasria
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | insulin glargine |
pharmaceutical drug |
|
Statements
C₂₆₇H₄₀₄N₇₂O₇₈S₆
0 references
